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Unusual cardiogenic shock due to pheochromocytoma: Recovery after
bridge-to-bridge (extracorporeal life support and DeBakey ventricular
assist device) and right surrenalectomy
J.-M. Grinda, MD,a M.-O. Bricourt, MD,a S. Salvi, MD,a M. Carlier, MD,b F. Grossenbacher, MD,b C. Brasselet, MD,c and
J.-N. Fabiani, MD,a Paris and Reims, France
Acute adrenergic cardiomyopathy resulting in intracta-ble pulmonary edema and life-threatening cardiogenicshock is an unusual revelation of a pheochromocytoma.1-4Dealing with such a patient, we have performed a
bridge-to-bridge (extracorporeal life support [ECLS] secondarily
switched for a DeBakey axial pump ventricular assist device) asso-
ciated to a right surrenalectomy, allowing cardiac function recovery.
Clinical Summary
A 49-year-old man with no previously known pathology or risk
factors complained of brutal abdominal pain, vomiting, headache, and
malaise. On arrival to his referring hospital, he presented with a
massive pulmonary edema, followed by cardiogenic shock and car-
diac arrest requiring cardiopulmonary resuscitation. Initial laboratory
findings showed troponin I and pro-brain natriuretic peptid levels at
0.23 g/L and 5667 pg/mL, respectively (normal, 0.06 g/L and
84 pg/mL, respectively). Arterial blood gases revealed a partial
oxygen pressure of 218 mm Hg at a fraction of inspired oxygen of 1.
Electrocardiography did not identify signs of ischemia or infarction,
and chest radiography showed bilateral infiltration consistent with
pulmonary edema. An echocardiogram revealed a severe global hy-
pokinesia (left ventricular ejection fraction, 12%) without ventricular
dilatation, no valvulopathy, no pulmonary artery hypertension, and a
nonincreased septal thickness. Hemodynamic and respiratory status
worsened despite mechanical ventilation, volume expansion, and an
intake of dobutamine (8g) and norepinephrine (2g). The results of
coronorography were normal, and during the procedure, an intra-
aortic balloon pump was introduced. A thoracoabdominal computed
tomographic (CT) scan revealed a 3 3-cm mass in the right adrenal
gland. The diagnosis was orientated toward pheochromocytoma, and
initial dosages of catecholamines were provided.
We were approached as the patient’s condition got worse with
signs of multiorgan failure. We then decided to implant an ECLS
device (Medos Delta stream) by means of peripheral cannulation
(common femoral artery and vein) in the referring hospital’s
emergency department (located 200 km from our department).
Medical transport, although risky, then ensued safely by road to
our institution. ECLS provided an adequate flow (4 L/min), allow-
ing norepinephrine and dobutamine disruption on day 2. The
dosage of catecholamines was consistent with the presumed diag-
nosis of pheochromocytoma: both epinephrine and norepinephrine
levels were high, at 12.5 nmol/L and 3.5 nmol/L (normal, 4
nmol/L), respectively, and the urinary vanyl mandelic acid value
was 81.23 mg/24 hours (normal, 7 mg/24 hours).
At day 4 on ECLS, the patient presented with an intractable
hypertension, despite triple therapy (calcium-channel blocker,
-–blocker, and vasodilator), which was soon followed by a
massive pulmonary edema. We decided to carry on with the
surgical treatment of pheochromocytoma and the placement of a
left ventricular assist device (DeBakey axial pump) as a bridge to
recovery.5
ECLS was used as extracorporeal circulation to achieve the
surgical procedure, including sternotomy, right subcostal laparot-
omy, right surrenalectomy, and DeBakey axial pump ventricular
assist device (Micromed) implantation. Histologic examination of
the adrenal gland confirmed the diagnosis of pheochromocytoma,
and cardiac biopsy specimens showed slight nonspecific changes
(hypertrophy and fibrosis). Blood and urinary samples for the
dosage of catecholamines were obtained on postoperative days 10
and 30. Norepinephrine was at 10.9 and 4.8 nmol/L, and epineph-
rine was at 0.54 nmol/L and nondetectable, respectively. Urinary
metanephrine was 3.8 mol/24 hours (normal, 3.7 mol/24
hours) and 1.3 mol/24 hours, respectively. Progressive cardiac
function recovery was confirmed by means of echocardiography
and an isotopic scintigraphy, allowing DeBakey ventricular assist
device explantation on day 70. The postoperative course was
uneventful, and the patient was discharged from the hospital on
day 90. At 12 months’ follow-up, he has recovered a normal
cardiac function (left ventricular ejection fraction, 60%). The tho-
racoabdominal control CT scan shows no abnormality.
Discussion
Unusual presentations of pheochromocytoma have been reported,
including dilated cardiomyopathy, pulmonary edema, cardiogenic
shock, sudden death, and even 2 cases of late diagnosis realized
after cardiac transplantation for dilated cardiomyopathy.4 The di-
agnosis is difficult and frequently made postmortem. To our
knowledge, this case is the first requiring mechanical circulatory
support ever published. For this patient, the diagnosis was rapidly
but fortuitously established on the basis of a systematic CT scan
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and later confirmed by dosages of catecholamines. The institution
of an early aggressive treatment was life saving.
Compared with the scheduled device implantation in patients
deteriorating on the waiting list, management of emergencies
requiring circulatory support is still a challenging situation. We
have developed in our unit a mobile kit of emergency circulatory
support to deal with this problem. This ECLS has become a useful
adjunct to our cardiac assist device program, allowing patient
transfer and secondary implantation of a more long-term sophis-
ticated device.
As expected in this catecholamine-induced cardiomyopathy,
the patient recovered after surgical resection of the tumor, but
recovery is not so fast as to allow the use of an ECLS device alone,
and implantation of a long-term device was mandatory.
Conclusion
Diagnosis and treatment of cardiogenic shock caused by pheochro-
mocytoma is difficult and can end in fatal evolution. This case
emphasizes the need for an early aggressive treatment to improve
the outcome of this surgically curable pathology.
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Percutaneous occlusion of a pseudoaneurysm evolving after homograft
aortic valve and root replacement with the Amplatzer muscular
ventricular septal defect occluder
Eric M. Graham, MD,a Varsha M. Bandisode, MD,a Andrew M. Atz, MD,a Charles H. Kline, RDMS,a
Marian H. Taylor, MD,b and John S. Ikonomidis, MD, PhD,c Charleston, SC
Aortic root replacement with aortic homograft hasyielded good results in appropriate patients. Aorticpseudoaneurysms are a rare postoperative complica-tion, potentially leading to reoperation with signifi-
cantly higher surgical mortality.1 We describe a case in which a
left ventricular outflow tract pseudoaneurysm is successfully oc-
cluded with transcatheter device closure in a patient at high risk for
reoperation.
Clinical Summary
A 40-year-old woman presented with a history of a bicuspid aortic
valve with severe insufficiency, ascending aortic aneurysm, and hemi-
arch aneurysm. After discussion of the various treatment options, she
underwent surgical replacement with a 22-mm homograft aortic
valve, root, and ascending aorta. Her midterm postoperative course
was complicated by gram-negative endocarditis and dehiscence of the
homograft. Her aortic homograft was rereplaced 22 days after initial
intervention and was complicated by uncontrollable bleeding from a
posterior annular suture line. An anterior pericardial baffle was cre-
ated and decompressed to the right atrial appendage, resulting in
hemostasis. At 48 days after the second surgical intervention, fol-
low-up revealed a persistent and increasing left-to-right shunt. At
surgical re-exploration, an unsuccessful attempt (caused by continued
bleeding) was made to repair the homograft at the posterior annulus,
requiring replacement of the pericardial baffle.
Serial computed tomographic angiography revealed closure of
the left-to-right shunt, but a contained pseudoaneurysm remained
in the lateral aspect of the left ventricular outflow tract directed
posteriorly between the left atrium and the aortic arch and draped
by the left main coronary artery. Serial evaluations revealed pro-
gressive enlargement of the pseudoaneurysm with tenting of the
left main coronary artery at its bifurcation.
Given her multiple reoperations, she was referred for transcath-
eter device occlusion of the pseudoaneurysm. Institutional review
board approval for compassionate use of the device, as well as
informed consent, was obtained. Transthoracic echocardiography
revealed a 3.5  1.6–cm pseudoaneurysm located posteriorly and
leftward of the aortic valve. The neck to the pseudoaneurysm
originated under the aortic valve within the left ventricular outflow
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